DW Healthcare Partners has sold Verathon, Inc., a manufacturer of proprietary medical devices and services, to Roper Industries, Inc. (NYSE: ROP).


December 9, 2009 - Roper Industries Inc. (NYSE: ROP) has acquired Verathon Inc., a Bothell, Wash.-based provider of medical devices and services like a noninvasive bladder-scan device. No financial terms were disclosed. Verathon has raised nearly $16 million, from firms like DW Healthcare Partners.

Roper Industries, Inc. (NYSE: ROP) today announced that it has completed the planned acquisition of Verathon, Inc. following the required regulatory and shareholder approval.

Headquartered in Bothell, Washington, Verathon is a leading global provider of proprietary medical devices and services. Verathon's noninvasive BladderScan instrument is a standard of care for portable ultrasound bladder volume measurement. The Company's GlideScope Video Laryngoscope improves intubation success for emergency departments, operating rooms and rapid response applications such as EMS and military applications. With a direct sales force of over 140 people, Verathon provides global coverage to hospitals, primary care physicians, acute care and military end markets.

"We are pleased to add Verathon, its leadership team and employees to our growing medical businesses," said Brian Jellison, Roper's President, Chairman and CEO. "Gerald McMorrow, Verathon's founder, has built a strong business and we look forward to continuing its growth, both organically and through acquisitions."

About Roper Industries

Roper Industries is a market-driven, diversified growth company and is a component of the Fortune 1000, S&P Midcap 400 and the Russell 1000 Indexes. Roper provides engineered products and solutions for global niche markets, including water, energy, radio frequency and research/medical applications. Additional information about Roper Industries is available on the Company's website at www.roperind.com

About DW Healthcare Partners

DW Healthcare Partners is a private equity firm focused exclusively on the healthcare industry. The firm manages over $250 million in committed capital and invests in profitable healthcare companies with proven management teams. DW Healthcare Partners is led by seasoned healthcare executives with more than 100 years of combined industry experience. The firm provides the capital, strategic guidance, and acquisition expertise to help mid- to late-stage companies realize their potential for growth. For more information, please visit www.dwhp.com